Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0649654B2 - Highly stable enteric useful bacterial preparation and method for producing the same - Google Patents
[go: Go Back, main page]

JPH0649654B2 - Highly stable enteric useful bacterial preparation and method for producing the same - Google Patents

Highly stable enteric useful bacterial preparation and method for producing the same

Info

Publication number
JPH0649654B2
JPH0649654B2 JP63294642A JP29464288A JPH0649654B2 JP H0649654 B2 JPH0649654 B2 JP H0649654B2 JP 63294642 A JP63294642 A JP 63294642A JP 29464288 A JP29464288 A JP 29464288A JP H0649654 B2 JPH0649654 B2 JP H0649654B2
Authority
JP
Japan
Prior art keywords
useful
substance
enteric
bacteria
powdery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63294642A
Other languages
Japanese (ja)
Other versions
JPH02142735A (en
Inventor
孝一 岩並
正次 伊藤
Original Assignee
日本油脂株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本油脂株式会社 filed Critical 日本油脂株式会社
Priority to JP63294642A priority Critical patent/JPH0649654B2/en
Publication of JPH02142735A publication Critical patent/JPH02142735A/en
Publication of JPH0649654B2 publication Critical patent/JPH0649654B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】 <産業上の利用分野> 本発明は、食品、飼料、医薬等の分野に使用可能な、高
安定性腸内有用細菌製剤及びその製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION <Industrial field of application> The present invention relates to a highly stable enteric useful bacterial preparation which can be used in the fields of food, feed, medicine and the like, and a method for producing the same.

<従来の技術> 乳酸菌等の腸内有用細菌は、腸内においてpHを低下させ
て酸性に保つことにより、他の細菌、特に大腸菌を始め
とするクラム陰性菌を抑え、これらの細菌の腸内への定
着及び増殖をも抑えて、細菌への感染を防止する作用が
ある。
<Prior Art> Useful enteric bacteria such as lactic acid bacteria suppress other bacteria, especially crumb-negative bacteria such as Escherichia coli, by keeping the pH in the intestine and keeping the acidity, and enterobacteria of these bacteria It also has the effect of preventing bacterial infection by suppressing colonization and proliferation of the bacteria.

近年、前記腸内有用細菌の作用を利用して、健康食品又
は整腸剤等への応用がなされているが、人間及び動物が
食する際、胃液のpHが低いために、前記腸内有用細菌が
腸に到達する前に大部分死滅するという問題が生じる。
そこで、前記腸内有用細菌を外部の要因から保護し、安
定化させる方法、例えば特開昭62−220186号公
報にはW/O/W型エマルジョンにおいて、水層に生菌
体を分散させる方法が、また特開昭62−201823
号公報又は特開昭62−263128号公報には、二重
若しくは三重ノズルを用いて生菌体を分散させた油脂
を、ゼラチンソフトカプセル中に封入させる方法が、更
に特開昭60−172280号公報又は特開昭60−1
88060号公報には、安定剤を添加した後に凍結乾燥
する方法等が提案されている。
Recently, by utilizing the action of the intestinal useful bacteria, it has been applied to health foods or intestinal preparations, etc., when humans and animals eat, because the pH of the gastric juice is low, the intestinal useful bacteria are The problem is that most of them die before they reach the intestine.
Therefore, a method of protecting the intestinal useful bacteria from external factors and stabilizing it, for example, a method of dispersing viable cells in an aqueous layer in a W / O / W type emulsion in JP-A-62-220186. In addition, JP-A-62-201823
JP-A-60-172280 discloses a method of encapsulating a fat / oil in which live cells are dispersed using a double or triple nozzle in a gelatin soft capsule, as disclosed in JP-A-60-172280. Or JP-A-60-1
Japanese Patent No. 88060 proposes a method of freeze-drying after adding a stabilizer.

しかしながら、W/O/W型エマルジョンを用いる方法
では、製剤化する際に粉体とすることが困難であり、ま
たノズルによる方法においても、粒子径が大きくなり、
他の製剤との配合に問題が生じる。更に芯物質である腸
内有用細菌の含有量が低いために、多くの製剤を使用す
る必要が生じ、経済的に不利である。更にまた被覆剤と
して、胃で分解されず、腸で分解される油脂を用いるこ
とが望まれるが、製剤を常温において粉末として取り出
すには、融点を40℃以上にする必要があり、該温度で
は一般的に腸内有用細菌の生存が困難である。従って被
覆剤として油脂を使用することができる腸内有用細菌製
剤及びその製造方法の開発が望まれている。
However, with the method using a W / O / W type emulsion, it is difficult to make a powder when formulating, and even with the method using a nozzle, the particle size becomes large,
There is a problem in blending with other formulations. Further, since the content of useful enteric bacteria as a core substance is low, it is necessary to use many preparations, which is economically disadvantageous. Furthermore, it is desirable to use as the coating agent an oil or fat that is not decomposed in the stomach but is decomposed in the intestine, but in order to take out the preparation as a powder at room temperature, it is necessary to have a melting point of 40 ° C. or higher. Generally, it is difficult for the useful bacteria in the intestine to survive. Therefore, it is desired to develop a useful enteric bacterial preparation that can use oils and fats as a coating agent and a method for producing the same.

<発明が解決しようとする課題> 本発明の目的は、被覆性能に優れ、食品、飼料又は医薬
等の分野において有効に使用できる高安定性腸内有用細
菌製剤及びその製造方法を提供することにある。
<Problems to be Solved by the Invention> An object of the present invention is to provide a highly stable enteric useful bacterial preparation which is excellent in coating performance and can be effectively used in the fields of food, feed or medicine, and a method for producing the same. is there.

本発明の別の目的は、芯物質である腸内有用細菌の含有
量を高めることができ、且つ少量の被覆剤によって、優
れた被覆性能を得ることができる経済的に非常に有利な
高安定性腸内有用細菌製剤及びその製造方法を提供する
ことにある。
Another object of the present invention is to increase the content of intestinal useful bacteria, which is the core substance, and to obtain excellent coating performance with a small amount of coating agent. To provide a useful enteric bacterial preparation and a method for producing the same.

本発明の更に別の目的は、被覆剤を溶融する必要がな
く、従って多大のエネルギーの消費が回避でき、また使
用装置の維持が容易な高安定性腸内有用細菌製剤の製造
方法を提供することにある。
Still another object of the present invention is to provide a method for producing a highly stable enteric useful bacterial preparation which does not require melting of the coating agent and therefore avoids the consumption of a large amount of energy and is easy to maintain the device to be used. Especially.

<課題を解決するための手段> 本発明によれば、腸内有用細菌を含む芯物質としての粉
状体と、該芯物質の全周囲表面を被覆する被覆剤として
の融点40℃以上の脂質粉状体とを含む腸内有用細菌製
剤であって、前記芯物質に前記被覆剤を接触・衝突させ
て芯物質を被覆してなる高安定性腸内有用細菌製剤が提
供される。
<Means for Solving the Problems> According to the present invention, a powdery substance as a core substance containing useful enteric bacteria, and a lipid having a melting point of 40 ° C. or higher as a coating agent for coating the entire peripheral surface of the core substance. A highly stable enteric useful bacterial preparation comprising a powdery substance, which comprises coating the core substance by contacting and colliding with the core substance.

また本発明によれば、腸内有用細菌を含む粉状体と、被
覆剤として融点40℃以上の脂質粉状体とを、混合比
(腸内有用細菌を含む粉状体体重量/被覆剤重量)0.
1〜50で接触・衝突させ、前記腸内有用細菌を含む粉
状体の全周囲表面に、前記脂質粉状体を付着・被覆させ
ることを特徴とする高安定性腸内有用細菌製剤の製造方
法が提供される。
Further, according to the present invention, a powdery body containing useful enteric bacteria and a lipid powdery substance having a melting point of 40 ° C. or higher as a coating agent are mixed at a ratio (weight of powdery body containing useful enteric bacteria / coating agent). Weight) 0.
Production of a highly stable enteric useful bacterial preparation characterized by contacting and colliding with each other at 1 to 50 to adhere and coat the lipid powder on the entire peripheral surface of the powder containing the enteric useful bacteria. A method is provided.

更にまた本発明によれば、前記芯物質に前記被覆剤を接
触・衝突させて得られる腸内有用細菌製剤に、更に親水
性物質を接触・衝突させて芯物質を被覆してなる高安定
性腸内有用細菌製剤が提供される。
Furthermore, according to the present invention, a highly stable intestinal useful bacterial preparation obtained by contacting and colliding the core substance with the coating agent, is further contacted with and collided with a hydrophilic substance to coat the core substance with high stability. An enteric useful bacterial preparation is provided.

更にまた本発明によれば、腸内有用細菌を含む粉状体
と、被覆剤として融点40℃以上の脂質粉状体とを、混
合比(腸内有用細菌を含む粉状体重量/被覆剤重量)
0.1〜50で接触・衝突させ、前記腸内有用細菌を含
む粉状体の全周囲表面に、前記脂質粉状体を付着・被覆
させ、次いで親水性物質を接触・衝突させて、前記腸内
有用細菌を含む粉状体に前記親水性物質を更に付着・被
覆させることを特徴とする高安定性腸内有用細菌製剤の
製造方法が提供される。
Furthermore, according to the present invention, a powdery body containing useful enteric bacteria and a lipid powdery substance having a melting point of 40 ° C. or higher as a coating agent are mixed at a ratio (weight of powdery body containing useful enteric bacteria / coating agent). weight)
0.1 to 50 contact / collision, the whole peripheral surface of the powdery substance containing the intestinal useful bacteria is adhered / coated to the lipid powdery substance, and then a hydrophilic substance is contacted / collided, There is provided a method for producing a highly stable enteric useful bacterial preparation, which comprises further adhering and coating the above-mentioned hydrophilic substance on a powder containing enteric useful bacteria.

以下本発明を更に詳細に説明する。The present invention will be described in more detail below.

本発明において使用できる芯物質としての腸内有用細菌
としては、例えばB.bifidum,B.breve,B.adolescentis,
B.infantis,B.longum等のBifidobacterium属、S.faecal
is,S.thermophilus等のstoreptococcus属、L.acidophil
us,L.bulgaricus,L.casei等のLactobcillus属等の公知
の腸内有用細菌を好ましく挙げることができる。使用に
際しては市販品を用いることができ、前記腸内有用細菌
を2種以上組合わせて使用することもできる。また前記
腸内有用細菌は、そのまま用いることができる他、例え
ば乳糖、リジン、アスパラギン酸、アルギニン等のアミ
ノ酸類、ゼラチン、アルブミン、ペプトン等の高分子物
質又はその分解物、脱脂粉乳若しくは水溶性ビタミン等
とともに凍結乾燥し、粉末化して用いることもできる。
Examples of useful enteric bacteria as the core substance that can be used in the present invention include B. bifidum, B. breve, B. adolescentis,
B.infantis, B.longum, etc., genus Bifidobacterium, S.faecal
genus storeptococcus such as is, S. thermophilus, L. acidophil
Known intestinal useful bacteria such as Lactobcillus genus such as us, L. bulgaricus, L. casei and the like can be preferably mentioned. When used, commercially available products can be used, and two or more of the intestinal useful bacteria can be used in combination. In addition, the intestinal useful bacteria can be used as they are, for example, amino acids such as lactose, lysine, aspartic acid, and arginine, polymeric substances such as gelatin, albumin, peptone, or their degradation products, skim milk powder, or water-soluble vitamins. It can also be freeze-dried together with the above and powdered.

本発明において、被覆剤として用いる融点40℃以上の
脂質粉状体としては、例えば天然から得られる牛脂、豚
脂、魚油等の動物脂、大豆油、菜種油、ヤシ油、綿実油
等の植物油及びこれらの油脂の硬化油、脂肪酸モノグリ
セライド、脂肪酸ジグリセライド、プロピレングリコー
ル脂肪酸エステル、ショ糖脂肪酸エステル、脂肪酸、高
級アルコール、ワックス、トコフェロール、リンと窒素
とを含むリン脂質、糖を構成成分に有する糖脂質、スル
ホン酸基を有するスルホリピッド、ステロール、炭化水
素及びこれらの硬化物等からなる群の1種又は2種以上
より選択することができる。
In the present invention, examples of the lipid powder having a melting point of 40 ° C. or higher used as a coating agent include beef tallow, lard, animal fats such as fish oil, soybean oil, rapeseed oil, coconut oil, cottonseed oil and the like, and vegetable oils obtained from these and the like. Hydrogenated oils, fatty acid monoglycerides, fatty acid diglycerides, propylene glycol fatty acid esters, sucrose fatty acid esters, fatty acids, higher alcohols, waxes, tocopherols, phospholipids containing phosphorus and nitrogen, glycolipids having sugar as a constituent, sulfone It can be selected from one or more selected from the group consisting of sulfolipids having an acid group, sterols, hydrocarbons and cured products thereof.

本発明に用いる前記腸内有用細菌を含む芯物質と、前記
被覆剤との混合比(腸内有用細菌を含む粉状体重量/被
覆剤重量)は、0.1〜50であり、その範囲外である
と完全に被覆された腸内有用細菌製剤が得られない。
The mixing ratio of the core substance containing the enteric useful bacteria used in the present invention and the coating agent (the weight of the powdery substance containing the enteric useful bacteria / the coating agent weight) is 0.1 to 50, and the range is within the range. Outside, no fully coated enteric beneficial bacterial preparations can be obtained.

本発明において、水系への添加分散性を改善するために
前記被覆剤を親水性物質により更に被覆することができ
る。該親水性物質としては、例えばトウモロコシ、馬鈴
薯等の澱粉、デキストリン、オリゴ糖、蛋白質等の親水
性高分子及びその分解物等からなる群の1種又は2種以
上より選択することができる。前記親水性物質の配合割
合は、本発明の腸内有用細菌製剤全体に対して、1〜2
0重量%の範囲で添加することが好ましい。
In the present invention, the coating agent may be further coated with a hydrophilic substance in order to improve the dispersibility in the aqueous system. The hydrophilic substance may be selected from one or two or more members selected from the group consisting of starch such as corn and potato, hydrophilic polymer such as dextrin, oligosaccharide and protein, and degradation products thereof. The mixing ratio of the hydrophilic substance is 1 to 2 with respect to the whole enteric useful bacterial preparation of the present invention.
It is preferably added in the range of 0% by weight.

本発明の腸内有用細菌製剤を製造するには、前記芯物質
である粉状体と、被覆剤である粉状体とを、例えばボー
ルミル、電気乳鉢、高能率粉体混合装置、高速気流の対
流等により、粉状体を互いに接触・衝突させることによ
って、前記芯物質の粉状体全表面に、被覆剤を付着・被
覆させることができる。また、水系への添加分散性を改
善するために、更に前記親水性物質を付着・被覆させる
場合も、同様な方法により接触・衝突させることによ
り、前記被覆剤を更に親水性物質で被覆するとこができ
る。この際接触・衝突は、あまり過激な条件で行うと、
粉状体の温度が上昇し、腸内有用細菌が死滅する恐れが
あるので、てきるだけ温和な条件で行うのが好ましい。
即ち、接触・衝突の際の粉状体温度は、40℃未満であ
れば十分である。更に被覆性性能を向上させるために、
予め前記芯物質である粉状体と被覆剤とを混合しておく
ことが望ましく、特に前記接触・衝突を数回に分けて行
うことが好ましい。
In order to produce the intestinal useful bacterial preparation of the present invention, the powder substance which is the core substance and the powder substance which is a coating material are, for example, a ball mill, an electric mortar, a highly efficient powder mixing device, and a high-speed air stream. By contacting and colliding the powdery substances with each other by convection or the like, the coating agent can be attached and coated on the entire surface of the powdery substance of the core substance. Further, in order to improve the dispersibility in addition to the water system, when the hydrophilic substance is further attached / coated, the coating agent may be further coated with the hydrophilic substance by contacting / colliding with the same method. You can At this time, if contact / collision is performed under extremely extreme conditions,
Since the temperature of the powdery substance may rise and useful bacteria in the intestine may be killed, it is preferable to perform the treatment under mild conditions as much as possible.
That is, it is sufficient that the temperature of the powdery body at the time of contact / collision is less than 40 ° C. To further improve the coating performance,
It is desirable to previously mix the powdery substance that is the core substance and the coating agent, and it is particularly preferable to perform the contact and collision in several times.

<発明の効果> 本発明の高安定性腸内有用細菌製剤及びその製造方法で
は、従来公知の製剤に比して、被覆性能を大幅に向上さ
せることができ、腸内有用細菌が胃の中で死滅すること
を有効に防ぐことが可能であるので、食品、飼料又は医
薬の分野において有用である。また芯物質である腸内有
用細菌の含有量を高め、且つ少量の被覆剤により優れた
被覆性能を得ることができるので、経済的に非常に有利
である。更に本発明の製造方法では、被覆剤を溶融する
必要がないので、エネルギーの消費が回避でき、また使
用装置の維持及び管理が容易である。
<Effects of the Invention> In the highly stable enteric useful bacterial preparation of the present invention and the method for producing the same, the coating performance can be significantly improved as compared with conventionally known preparations, and enteric useful bacteria are present in the stomach. It is useful in the field of food, feed or medicine because it can be effectively prevented from dying. Further, the content of useful enteric bacteria as a core substance can be increased, and excellent coating performance can be obtained with a small amount of coating agent, which is very economically advantageous. Further, in the production method of the present invention, since it is not necessary to melt the coating material, energy consumption can be avoided, and maintenance and management of the device used is easy.

<実施例> 以下本発明を実施例及び比較例により更に詳細に説明す
るが、本発明はこれらに限定されるものではない。
<Examples> The present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

実施例1 乳酸菌(S.Faecalis)(1.25×1010個/g)70
0gに、牛脂硬化油微粉末300gを加え混合した後、
奈良ハイブリダイゼーションシステム(株式会社奈良機
械製作所製)を用いて3分間混合処理した。得られた粉
末842gを、温度35℃、湿度65%下において3ヶ
月間保存試験を行なって、腸内有用細菌の減少を測定し
た。その結果を表1に示す。
Example 1 Lactic acid bacteria (S. Faecalis) (1.25 × 10 10 cells / g) 70
After adding 300 g of hardened beef tallow oil powder to 0 g and mixing,
The mixture was mixed for 3 minutes using a Nara hybridization system (manufactured by Nara Machinery Co., Ltd.). 842 g of the obtained powder was subjected to a storage test for 3 months at a temperature of 35 ° C. and a humidity of 65% to measure the decrease of intestinal useful bacteria. The results are shown in Table 1.

比較例1 実施例1で使用した乳酸菌(S.Faecalis)(1.25×1
10個/g)700gを用いて、実施例1と同様に保
存試験を行った。その結果を表1に示す。
Comparative Example 1 The lactic acid bacterium (S. Faecalis) used in Example 1 (1.25 × 1)
A storage test was conducted in the same manner as in Example 1 using 700 g of ( 10 cells / g). The results are shown in Table 1.

以上より、本発明による製剤は、三ヶ月間の保存におい
て、わずかな菌の減少しかみられなかった。
From the above, the formulation according to the present invention showed only a slight reduction in the bacteria during storage for 3 months.

実施例2 乳酸菌(B.longum)(1.76×1010個/g)354
gに、菜種硬化油微粉末150gを加えヘンシルミキサ
ーにより1000r.p.mで16分間混合処理した後、さ
らに菜種硬化油微粉末154gを加え4分間混合処理し
た。次いで得られた粉末に、さらにコーンスターチ50
gを加え、同様の混合処理を3分間行ない、668gの
粉末を得た。得られた粉末を日本薬局方崩壊試験法第一
液(pH1.2)に懸濁させ、37℃で2時間撹拌した
後、pHを6.5に調製し、ビフィズス菌の原菌数に対す
る生存菌の比率を測定することにより、耐酸性試験を行
なったところ、生存率は64.2%であった。
Example 2 Lactobacillus (B. longum) (1.76 × 10 10 cells / g) 354
150 g of rapeseed hydrogenated oil fine powder was added to g, and mixed with a Hensyl mixer at 1000 rpm for 16 minutes, and then 154 g of rapeseed hydrogenated oil fine powder was further added and mixed for 4 minutes. Then the obtained powder is further added to cornstarch 50
g was added, and the same mixing treatment was performed for 3 minutes to obtain 668 g of powder. The obtained powder was suspended in the Japanese Pharmacopoeia disintegration test method 1st solution (pH 1.2), stirred at 37 ° C. for 2 hours, adjusted to pH 6.5, and viable against the number of bifidobacteria. When the acid resistance test was conducted by measuring the ratio of the bacteria, the survival rate was 64.2%.

比較例2 実施例2で使用した乳酸菌(B.longum)(1.76×10
10個/g)354gを用いて、実施例2とに同様に耐
酸性試験を行ったところ生存率は0.4%であった。
Comparative Example 2 The lactic acid bacterium (B. longum) used in Example 2 (1.76 × 10 6)
An acid resistance test was conducted in the same manner as in Example 2 using 354 g ( 10 pieces / g), and the survival rate was 0.4%.

実施例3 乳酸菌(L.acidophilus)(1.60×1010個/g)
480gに、ステアリン酸モノグリセライド微粉末12
0gを加え混合した。次に奈良ハイブリダイゼーション
システム(株式会社奈良機械製作所製)で4分間混合処
理した後、更にライスワックス微粉末150gを加え4
分間混合処理した。次いで得られた粉末に、更に乳糖5
0gを加え、同様に混合処理を2分間行ない、687g
の粉末を得た。得られた粉末について実施例2と同様に
耐酸性試験を行なったところ76.7%であった。
Example 3 L. acidophilus (1.60 × 10 10 cells / g)
480 g, stearic acid monoglyceride fine powder 12
0 g was added and mixed. Next, after mixing for 4 minutes with a Nara hybridization system (manufactured by Nara Machinery Co., Ltd.), 150 g of fine rice wax powder was further added,
Mixed for a minute. Next, lactose 5 was added to the obtained powder.
0g was added, and the same mixing treatment was performed for 2 minutes, 687g.
Of powder was obtained. When an acid resistance test was conducted on the obtained powder in the same manner as in Example 2, the result was 76.7%.

比較例3 実施例3で使用した乳酸菌(L.acidophilus)(1.60
×1010個/g)480gを用いて、実施例2と同様
に耐酸性試験を行ったところ生存率は0.3%であっ
た。
Comparative Example 3 L. acidophilus (1.60 used in Example 3)
When an acid resistance test was conducted in the same manner as in Example 2 using 480 g of x10 10 cells / g), the survival rate was 0.3%.

以上の結果より、耐酸性試験においても、本発明の腸内
有用細菌製剤が優れていることが判った。
From the above results, it was found that the intestinal useful bacterial preparation of the present invention was excellent even in the acid resistance test.

フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 A61K 9/50 M 7329−4C Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location A61K 9/50 M 7329-4C

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】腸内有用細菌を含む芯物質としての粉状体
と、該芯物質の全周囲表面を被覆する被覆剤としての融
点40℃以上の脂質粉状体とを含む腸内有用細菌製剤で
あって、前記芯物質に前記被覆剤を接触・衝突させて芯
物質を被覆してなる高安定性腸内有用細菌製剤。
1. A useful enteric bacterium comprising a powdery substance as a core substance containing enteric useful bacteria and a lipid powdery substance having a melting point of 40 ° C. or higher as a coating agent for coating the entire peripheral surface of the core substance. What is claimed is: 1. A highly stable enteric useful bacterial preparation obtained by contacting and colliding the coating material with the core substance to coat the core substance.
【請求項2】腸内有用細菌を含む粉状体と、被覆剤とし
て融点40℃以上の脂質粉状体とを、混合比(腸内有用
細菌を含む粉状体重量/被覆剤重量)0.1〜50で接
触・衝突させ、前記腸内有用細菌を含む粉状体の全周囲
表面に、前記脂質粉状体を付着・被覆させることを特徴
とする高安定性腸内有用細菌製剤の製造方法。
2. A powdery material containing useful enteric bacteria and a lipid powdery substance having a melting point of 40 ° C. or higher as a coating agent (mixing ratio (weight of powdery material containing useful enteric bacteria / weight of coating agent)) 0 A highly stable enteric useful bacterial preparation characterized by contacting and colliding at 1 to 50 to adhere and coat the lipid powder on the entire peripheral surface of the powder containing the enteric useful bacteria. Production method.
【請求項3】腸内有用細菌を含む芯物質としての粉状体
と、該芯物質の全周囲表面を被覆する被覆剤としての融
点40℃以上の脂質粉状体と、該脂質粉状体を被覆する
親水性物質とを含む腸内有用細菌製剤であって、前記芯
物質に前記被覆剤を接触・衝突させて得られる被覆製剤
に、更に前記親水性物質を接触・衝突させて芯物質を被
覆してなる高安定性腸内有用細菌製剤。
3. A powdery substance as a core substance containing intestinal useful bacteria, a lipid powdery substance having a melting point of 40 ° C. or higher as a coating agent for coating the entire peripheral surface of the core substance, and the lipidic powdery substance. Which is a useful enteric bacterial preparation containing a hydrophilic substance for coating a core substance by further contacting and colliding the hydrophilic substance with a coated preparation obtained by contacting and colliding the core substance with the coating agent. A highly stable intestinal useful bacterial preparation comprising:
【請求項4】腸内有用細菌を含む粉状体と、被覆剤とし
て融点40℃以上の脂質粉状体とを、混合比(腸内有用
細菌を含む粉状体重量/被覆剤重量)0.1〜50で接
触・衝突させ、前記腸内有用細菌を含む粉状体の全周囲
表面に、前記脂質粉状体を付着・被覆させ、次いで親水
性物質を接触・衝突させて、前記腸内有用細菌を含む粉
状体に前記親水性物質を更に付着・被覆させることを特
徴とする高安定性腸内有用細菌製剤の製造方法。
4. A powdery material containing useful enteric bacteria and a lipid powdery substance having a melting point of 40 ° C. or higher as a coating agent, in a mixing ratio (weight of powdery material containing useful enteric bacteria / weight of coating agent) of 0. 1 to 50, the lipid powder is adhered and coated on the entire peripheral surface of the powder containing the intestinal useful bacteria, and the hydrophilic substance is then contacted and collided to form the intestine. A method for producing a highly stable enteric useful bacterial preparation, which comprises further adhering and coating the hydrophilic substance on a powder containing the internal useful bacteria.
JP63294642A 1988-11-24 1988-11-24 Highly stable enteric useful bacterial preparation and method for producing the same Expired - Fee Related JPH0649654B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63294642A JPH0649654B2 (en) 1988-11-24 1988-11-24 Highly stable enteric useful bacterial preparation and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63294642A JPH0649654B2 (en) 1988-11-24 1988-11-24 Highly stable enteric useful bacterial preparation and method for producing the same

Publications (2)

Publication Number Publication Date
JPH02142735A JPH02142735A (en) 1990-05-31
JPH0649654B2 true JPH0649654B2 (en) 1994-06-29

Family

ID=17810409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63294642A Expired - Fee Related JPH0649654B2 (en) 1988-11-24 1988-11-24 Highly stable enteric useful bacterial preparation and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0649654B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02200639A (en) * 1989-01-31 1990-08-08 Shinfusou Seiyaku Kk Lipid coated bacterium preparation
IT1270216B (en) * 1994-06-14 1997-04-29 Recordati Chem Pharm METHOD OF STABILIZATION OF BIOLOGICALLY ACTIVE COMPOUNDS BY MICROGRANULES COVERED SUSPENDABLE IN FOOD FLUIDS
US5789014A (en) 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
JPWO2005025609A1 (en) * 2003-09-10 2007-11-08 株式会社Nrlファーマ Lactoferrin material composition
US8871266B2 (en) 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
WO2006082824A1 (en) * 2005-02-03 2006-08-10 Nrl Pharma, Inc. Matrix-type enteric coated sustained release composition
DE102006001554A1 (en) 2006-01-05 2007-07-12 Ipc Process-Center Gmbh & Co. Micropellets for the production of pet food pellets
DE102006001553A1 (en) * 2006-01-05 2007-07-19 Ipc Process-Center Gmbh & Co. Particles with sensitive component contained therein

Also Published As

Publication number Publication date
JPH02142735A (en) 1990-05-31

Similar Documents

Publication Publication Date Title
JP6033998B2 (en) Probiotic storage and delivery
JP6240386B2 (en) Probiotic stabilization
US20190328670A1 (en) Microparticles for Oral Delivery
Ozyurt et al. Properties of probiotics and encapsulated probiotics in food
RU2549098C2 (en) Thermostable probiotic compositions and healthy food on their basis
US11123384B2 (en) Microencapsulated probiotic bacteria
CN113329733A (en) Topical compositions comprising viable microorganisms
Das et al. Microencapsulation of probiotic bacteria and its potential application in food technology
EP3982921A1 (en) A gel composition comprising viable microorganisms
JPH0649654B2 (en) Highly stable enteric useful bacterial preparation and method for producing the same
JP2968089B2 (en) Coating material and enteric-coated granules using the same
JP3202053B2 (en) Enteric granules
JP3187502B2 (en) Enteric granules
CN113543645A (en) Enteric composition, food and drink containing the same, method for controlling disintegration time of the enteric composition, and method for producing the same
JPH02200639A (en) Lipid coated bacterium preparation
JPH06133735A (en) Enteric-coated lactic acid bacteria granules
AU2004275438B2 (en) Probiotic storage and delivery
EP2450034A1 (en) Formulation based on the synthesis of microspheres made from cross-linked natural gelatine, used as a carrier for strains of probiotic lactobacillus spp. for treating skin wounds and/or lesions
HK40071394A (en) Probiotic stabilization
Champagne K. Kailasapathy, University of Western Sydney, Australia
HK1172822A (en) Probiotic stabilization

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees